Literature DB >> 15231575

Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model.

Sherrill J Slichter1, Douglas Fish, V Kraig Abrams, Lakshmi Gaur, Karen Nelson, Doug Bolgiano.   

Abstract

The effectiveness of different methods of leukoreduction in preventing alloimmune platelet refractoriness was evaluated in a canine model. Platelets from a random donor dog were administered for up to 8 weeks or until platelet refractoriness. Standard (STD; unmodified) platelets were accepted by 14% of recipients (n = 7) compared with 14% for centrifuge leukoreduced (C-LR) platelets (n = 21) and 31% for filter leukoreduced (F-LR) platelets (n = 13; no significant differences). Surprisingly, using both F-LR and C-LR platelets was highly effective (87% acceptance, n = 15). Transfusing F-LR/C-LR red blood cells (n = 4) or F-LR/C-LR plasma (n = 4), along with F-LR/C-LR platelets, did not affect platelet acceptance (100% acceptance). Overall acceptance of F-LR/C-LR platelets was 91% (n = 23; P < or = .05 versus STD, C-LR, or F-LR platelets). F-LR/C-LR transfusions also induced tolerance to subsequent STD platelet transfusions from the same donor (82% acceptance, n = 19) as well as to donor skin grafts without recipient immunosuppression (57% acceptance, n = 7). To evaluate mechanisms of tolerance induction, F-LR/C-LR platelets were gamma-irradiated. Although the gamma-irradiated F-LR/C-LR platelets were uniformly accepted (n = 6), tolerance to STD platelets was lost. These data suggest that some allostimulatory white cells are filter adherent, whereas others escape filtration but can be removed by centrifugation and tolerance requires a residual functioning white cell.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231575     DOI: 10.1182/blood-2003-08-2942

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Polymorphisms in canine platelet glycoproteins identify potential platelet antigens.

Authors:  Mary Beth Callan; Petra Werner; Nicola J Mason; Geralyn M Meny; Michael G Raducha; Paula S Henthorn
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

2.  UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.

Authors:  Axel Seltsam; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2011-01-22       Impact factor: 3.747

Review 3.  Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Authors:  Seema R Patel; James C Zimring
Journal:  Transfus Med Rev       Date:  2013-10-03

4.  A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen-reduced platelets in mice.

Authors:  Rachael P Jackman; John W Heitman; Marcus O Muench
Journal:  Vox Sang       Date:  2020-03-23       Impact factor: 2.144

5.  Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.

Authors:  Jose A Cancelas; Jamie R Genthe; Moritz Stolla; Neeta Rugg; S Lawrence Bailey; Shawnagay Nestheide; Beth Shaz; Samantha Mack; Kadi Schroeder; Waseem Anani; Zbigniew M Szczepiorkowski; Larry J Dumont; Subramanian Yegneswaran; Laurence Corash; Nina Mufti; Richard J Benjamin; Anna C Erickson
Journal:  Transfusion       Date:  2022-07-09       Impact factor: 3.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.